What are you using for ANCA vasculitis maintenance? Not much difference in AZA vs. RTX on demand 70% relapse free in RTX q6 month for 18 months NO difference in similar 36 month group Should maintenance w/ RTX only last for 18 months? Food for thought @RheumNow #ACRbest https://t.co/zNdIEODpeS

NEJM: Clinical Examination of the Cervical Spine (full read, with video). Great overview of Cx exam, useful in evaluation of axial neck pain, radiculopathy, or myelopathy; info on dermatomes, reflexes, Lhermites sign, etc https://t.co/QYD1ZahqTS https://t.co/K0XhlHYXoz

Novel approach to ank spond. Case report. #YearinReview #ACR23 @RheumNow https://t.co/fWb1qdEcOS

Very cool targeted T cell ab treatment against TRBV9+ T cells provided remission in ankylosing spondylitis! Albeit only case report However Phase 2 ongoing @RheumNow #ACR23 https://t.co/pm64QeTo1U

Brilliant summary slide re:RA and PsA during an as-always entertaiing by Dr. Seo Personal opinion? -Persolimab will have narrow role & may cause CA -BIME will be 2nd line for PsA -Tyk-2's will be the next big thing Also... time for H2H trials!!! @RheumNow #ACR23 https://t.co/lDvsK8h7WH

#ACR23 YiR! Dr. P. Seo reviews 2023 novel therapeutic agents we may see on the horizon. @RheumNow https://t.co/d0V41jAh3G

Considering a career in Rheumatology? Dr. Philip Seo shares latest data from Lancet Rheumatology on the burden of disease of MSK disorders 👉123%⬆️since 1990 👉⬆️by 50% in 2050! Year in Review #ACR23 @RheumNow @rheumarhyme @doktora_ging @PhRheumaJr https://t.co/iypUn9MTu6

Can colchine reduce need for knee/hip replacement? Dr Seo #YearReview #ACR23 @RheumNow https://t.co/EpMl2nDZQ6

NORD-STAR study RA pts treated with MTX + certolizumab, abatacept, tocilizumab or triple therapy Certolizumab and Abatacept share 1st place! Toci 2nd Should we place abatacept higher on the RA tx hierarchy? @RheumNow #ACR23 https://t.co/QvyzkLOcmX

Still disgesting NORD-STAR, kind of surprised by the TCZ response? As per usual, ABA is probably an under-used option for RA @RheumNow #ACR23 https://t.co/QKyeuhqnXB

Novel therapeutics for #inflammatoryArthritis #YearInReciew #ACR23 @RheumNow https://t.co/9flVkGRn8v

Novel therapeutics for #SLE and #SSc #ACR23 @RheumNow https://t.co/yBSaTpNZLN